Skip to main content

Women develop Alzheimer's more than men due to hormones.

ALZHEIMER'S IN WOMEN :

A detailed new brain imaging study , examining a number of cognitively healthy middle aged subject is suggesting lower levels of estrogen in women post-menopause could play a role in triggering brain changes linked to Alzheimer's disease. The research hypothesizes this mechanism may be one of the reason why women suffer from Alzheimer's disease.


The research hypothesizes this mechanism may be one of the reason why women suffer from Alzheimer's at greater rates than men.
"About two-thirds of people living with Alzheimer's are women , and the general tend to live longer ," says Lisa Mosconi , an author on the new study from Weill Cornell Medicine.

However , over recent years many researchers have started exploring potential physiological reasons why there is suck start sex-specific differences in Alzheimer's cases.
One novel study last year , for example , pointed to a number of sex-specific genes that could heighten Alzheimer's risk in women , while another suggested structural and functional differences in female brains may accelerate the spread of toxic proteins.

This new study builds on what researchers have dubbed the "estrogen hypothesis". This hypothesis posits that women appear to show a heightened susceptibility to Alzheimer's because the drop in estrogen levels following menopause may exacerbate a predisposition to the brain changes associated with the neurodegenerative disease.

Based on this nascent hypothesis , the new research recruited 85 women and 36 women aged between 40 and 65 . All subjects were cognitively healthy and participated in detailed MRI and PET scans to measure four Alzheimer's related biomarkers, including levels of amyloid protein accumulations and rates of glucose metabolism.

Compared to the male control group , the women on average had 30% more amyloid accumulation , 22% lower glucose metabolism , and around 11 % less gray and white matter volume. Controlling for variables , the study found menopausal status was the most consistent predictor for these Alzheimer"s biomarkers , adding some weight to the estrogen hypothesis.

"While all sex hormones are likely involved , our findings suggest that declines in estrogen are involved in the Alzheimer's biomarkers abnormalities in women we observed , "says Mosconi" . The pattern of gray matter loss in particular shows anatomical overlap with the brain estrogen network.

The researchers say more work is needed before any conclusive recommendation is made regarding hormone replacement therapy for Alzheimer's risk reduction. It is also important to remember that Alzheimer's risk reduction. It is also important to remember that Alzheimer's is a significantly heterogenous disease , involving a complex volume of genetic and environmental factors. So obviously an estrogen decline following menopause cannot be considered a sole trigger for Alzheimer's in women.
Labels:

Comments

Post a Comment

If you have any doubt. Let me know

Popular posts from this blog

DID PLACEBO EFFECT WORKS?

what is placebo effect? It is a phenomenon in which some people experience a benefit after the administration of inactive substance. A placebo is a fake treatment that in some cases it can produce a realistic result. This depends upon the expectation of the patient,the more a paerson expects the treatment will work, it is more likely to respond. Things that will influence the placebo effect includes                                                                          The nature of illness The belief system of the patient during treatment The expectation of the patient if fulfilling The positive message from the doctor about treatment EFFECT ON HORMONES Taking the placebo tretament triggered the release of endorphins. Endorphins have a similar structure as morphine and other opiate painkillers and act as the brains own natural painkillers. Other possible things include conditioning , motivation and expectation. People who are highly motivated
2 comments
Read more

CAN YOU DIE FROM RHEUMATOID ARTHRITIS(RA)?

WHAT IS RHEUMATOID ARTHRITIS(RA)? Rheumatoid Arthritis(RA) is an autoimmune disease that can cause joint pain and damage throughout your body. It is a chronic disease marked by symptoms of inflammation and pain in the joints. It can also cause inflammation of organs such as the lungs, eyes, skin, and heart. There is no cure for RA, but medications can stop the progression of the disease  and ease symptoms. The  joint damage that RA causes usually happens on both sides of the body. Treatment is possible when RA is diagnosed early. SIGNS AND SYMPTOMS The sign and symptoms of RA come and go, depending upon the degree of inflammation. When the body tissues are inflammed, the disease is active and when the tissue inflammation subsides the disease is inactive. THE SIGN AND SYMPTOMS INCLUDE; Fatigue low grade fever muscle and joint pain joint tenderness joint deformity loss of energy rheumatoid nodules loss of joint function limping stiffness Muscle and joint stiffness are usually seen in the
2 comments
Read more

DID FABIFLU IS THE MEDICINE OF COVID-19 ?

Fabiflu in COVID-19  As we know the vaccine is still a long distance away and no sign of the coronavirus infections slowing down in the country , homegrown pharmaceutical companies have been given permission to launch generic versions of Remdesivir and Favipiravir , anti-viral drugs that have shown promise in treating Covid-19 patients. Glenmark pharmaceuticles has launched favipiravir under the brand name FabiFlu for treatment of mild to moderate cases of Covid-19 , cipla and hetero labs have received approvals from the Drug Controller General of India to launch generic versions of Remedesivir under the names Cipremi and Covifor respectively. While medical experts have cautioned against seeing these potential drugs as a "magic bullet" against the deadly virus , they can be helpful in reducing the viral load as India continues to post new record highs in infection on a daily basis. Remedesivir and Favipiravir are two of the 130 under experimentation drugs worldwide to treat c
1 comment
Read more